Iridex (NASDAQ: IRIX)
Q2 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2022-08-11 | ||||||
REV |
Q1 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.160 | -0.150 | 0.0100 | ||||
REV | 13.410M | 13.387M | -23.000K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Iridex (NASDAQ: IRIX) through any online brokerage.
Other companies in Iridex’s space includes: Sonendo (NYSE:SONX), Vapotherm (NYSE:VAPO), Pro-Dex (NASDAQ:PDEX), Venus Concept (NASDAQ:VERO) and Modular Medical (NASDAQ:MODD).
The latest price target for Iridex (NASDAQ: IRIX) was reported by Roth Capital on Wednesday, May 12, 2021. The analyst firm set a price target for 11.00 expecting IRIX to rise to within 12 months (a possible 313.53% upside). 0 analyst firms have reported ratings in the last year.
The stock price for Iridex (NASDAQ: IRIX) is $2.66 last updated July 5, 2022, 8:00 PM UTC.
There are no upcoming dividends for Iridex.
Iridex’s Q2 earnings are confirmed for Thursday, August 11, 2022.
There is no upcoming split for Iridex.
Iridex is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.